These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2539677)

  • 1. Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.
    Metselaar HJ; Velzing J; Rothbarth PH; Balk AH; Mochtar B; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2504-5. PubMed ID: 2539677
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
    Eisenmann D; Knipp H; Laube H; Stegmann T
    Transplant Proc; 1990 Oct; 22(5):2322-3. PubMed ID: 2171169
    [No Abstract]   [Full Text] [Related]  

  • 5. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
    Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B
    J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients].
    Bordigoni P; Janot C; Aymard JP; Witz F; Bené MC; Legras B; Schoonemann F; Olive D; Streiff F
    Nouv Rev Fr Hematol (1978); 1987; 29(5):289-93. PubMed ID: 2830588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
    Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic cytomegalovirus management strategies.
    Martin M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
    [No Abstract]   [Full Text] [Related]  

  • 15. A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England.
    Wreghitt TG; Hakim M; Gray JJ; Kucia S; Cory-Pearce R; Wallwork J; English TA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2495-6. PubMed ID: 2856284
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral antibodies in transplantation.
    Snydman DR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):10-2. PubMed ID: 7482809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperimmunoglobulin treatment in CMV infections following heart transplantation].
    Cremer J; Schäfers HJ; Wahlers T; Fieguth HG; Milbradt H; Flik J; Haverich A
    Dtsch Med Wochenschr; 1988 Jan; 113(1):18-20. PubMed ID: 2826099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin.
    Fassbinder W; Bechstein PB; Scheuermann EH; Schoeppe W
    Scand J Urol Nephrol Suppl; 1985; 92():23-8. PubMed ID: 3008313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transient HIV-antibody positive tests in heart transplantation patients after repeated administration of a CMV immune globulin preparation].
    Flik J; Milbradt H; Wahlers T; Schäfers HJ; Haverich A
    Dtsch Med Wochenschr; 1987 Jan; 112(5):178-81. PubMed ID: 3026767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.